論文（英文）
Hara F, Takashima T, Tsurutani J, Saito T, Taira N, Kashiwabara K, Aihara T, Mukai H. Randomized, optimal dose finding, phase II study of tri-weekly nabpaclitaxel in patients with metastatic breast cancer (ABROAD). Journal of Clinical Trials 2016; 6(3): Article 267. Doi:10.4172/2167-0870.1000267.
Hara F, Takashima T, Tsurutani J, Saito T, Taira N, Kashiwabara K, Aihara T, Mukai H. Randomized, optimal dose finding, phase II study of tri-weekly nabpaclitaxel in patients with metastatic breast cancer (ABROAD). Journal of Clinical Trials 2016; 6(3): Article 267. Doi:10.4172/2167-0870.1000267.
Hara F, Takashima T, Tsurutani J, Saito T, Taira N, Kashiwabara K, Aihara T, Mukai H. Randomized, optimal dose finding, phase II study of tri-weekly nabpaclitaxel in patients with metastatic breast cancer (ABROAD). Journal of Clinical Trials 2016; 6(3): Article 267. Doi:10.4172/2167-0870.1000267.